Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-112511
Filing Date
2013-03-18
Accepted
2013-03-18 16:07:56
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 d496370d10qa.htm 10-Q/A 438506
2 EX-31.1 d496370dex311.htm EX-31.1 6135
3 EX-31.2 d496370dex312.htm EX-31.2 6155
4 EX-32.1 d496370dex321.htm EX-32.1 2750
5 EX-32.2 d496370dex322.htm EX-32.2 2781
  Complete submission text file 0001193125-13-112511.txt   2139198

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20120331.xml EX-101.INS 314930
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20120331.xsd EX-101.SCH 11349
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20120331_cal.xml EX-101.CAL 32442
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20120331_def.xml EX-101.DEF 8624
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20120331_lab.xml EX-101.LAB 104024
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20120331_pre.xml EX-101.PRE 70807
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-31361 | Film No.: 13697716
SIC: 2834 Pharmaceutical Preparations